Results 281 to 290 of about 1,818,543 (386)
Protein‐Like Polymers Targeting Keap1/Nrf2 as Therapeutics for Myocardial Infarction [PDF]
Joshua M. Mesfin +17 more
openalex +1 more source
The advent of aptamers has highlighted their potential as alternatives to antibodies, overcoming limitations of structural instability and production cost. However, conventional approaches such as SELEX remain slow and labor‐intensive. This review examines recent advances in aptamer engineering, emphasizing in vitro and AI‐driven in silico strategies ...
John V. L. Nguyen +5 more
wiley +1 more source
Adaptation of a person-centred care intervention to enhance self-efficacy in patients following a myocardial infarction (P2MIR): a qualitative study exploring the needs and preferences of key stakeholders within a Portuguese healthcare context. [PDF]
Silva C +3 more
europepmc +1 more source
Higher plasma leucine is associated with increased risk of new‐onset myocardial infarction. Leucine deprivation alleviates advanced atherosclerosis in mice. Tumor‐induced leucine deprivation reprograms macrophage metabolism and increases CD5Lhi macrophages in mouse plaques. Mechanistically, leucine deficiency reduced SLC7A5‐PGAM5 binding in macrophages,
Shan Zhong +22 more
wiley +1 more source
Conservative versus surgical treatment in the management of cerebellar infarction: A meta-analysis. [PDF]
Xiang Y +6 more
europepmc +1 more source
Sclerostin loop2‐ApoER2 interaction in macrophages is required by sclerostin to suppress NF‐κB nuclear translocation and phosphorylation, to promote macrophage conversion into anti‐inflammatory subtypes in atherosclerotic aortas, as well as to prevent atherosclerosis and aortic aneurysm development in ApoE−/− mice. Abstract Therapeutic antibody against
Luyao Wang +27 more
wiley +1 more source
Transfer Learning Strategies for Cardiovascular Disease Detection in ECG Imagery. [PDF]
Soudagar A +6 more
europepmc +1 more source

